Markets:

Overview

News

Currencies

International

Treasuries

BioAtla, Inc. - Common Stock (NQ:BCAB)

3.355 -0.565 (-14.41%)

Streaming Delayed Price Updated: 11:23 AM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioAtla, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

Earnings Outlook For BioAtla ↗

March 26, 2025

Via Benzinga

BCAB Stock Earnings: BioAtla Meets EPS for Q2 2024 ↗

August 08, 2024

BCAB stock results show that BioAtla met analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

BCAB Stock Earnings: BioAtla Beats EPS for Q1 2024 ↗

May 14, 2024

BCAB stock results show that BioAtla beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

BCAB Stock Earnings: BioAtla Beats EPS for Q4 2023 ↗

March 26, 2024

BCAB stock results show that BioAtla beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 20, 2024

Via Benzinga

'Big Short' Investor Michael Burry's China Bet Pays Off As Top Picks Surge Nearly 60% In 2 Months ↗

October 09, 2024

Michael Burry, the investor renowned for his prescient bet against the housing market before the 2008 financial crisis, has seen his recent wager on Chinese stocks pay significant dividends.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 02, 2024

Via Benzinga

BioAtla: Q4 Earnings Insights ↗

March 26, 2024

Via Benzinga

Preview: BioAtla's Earnings ↗

March 25, 2024

Via Benzinga

Analyst Ratings for BioAtla ↗

September 25, 2023

Via Benzinga

BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody

September 23, 2024

From Context Therapeutics Inc.

Via GlobeNewswire

'Big Short' Fame Michael Burry Bets Big On China, Reveals Alibaba As Top Holding — JD.com And Baidu Also Feature On Scion's Portfolio ↗

August 15, 2024

Famed investor Michael Burry, known for his prescient bet against the housing market before the 2008 financial crisis, has made significant changes to his hedge fund's portfolio in the second quarter...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 02, 2024

Via Benzinga

Earnings Scheduled For March 26, 2024 ↗

March 26, 2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.

Via Benzinga

Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

December 20, 2023

The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

December 20, 2023

From BioAtla, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 18, 2023

Via Benzinga

BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event

December 05, 2023

From BioAtla, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 04, 2023

Via Benzinga

BioAtla to Participate in the JMP Securities Hematology and Oncology Summit

November 30, 2023

From BioAtla, Inc.

Via GlobeNewswire

BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC

November 28, 2023

From BioAtla, Inc.

Via GlobeNewswire

BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress

November 07, 2023

From BioAtla, Inc.

Via GlobeNewswire

BioAtla to Participate in the Jefferies London Healthcare Conference

November 06, 2023

From BioAtla, Inc.

Via GlobeNewswire

BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award

October 12, 2023

Award recognizes Dr. Short’s contribution to science innovation

From BioAtla, Inc.

Via GlobeNewswire

BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023

October 10, 2023

From BioAtla, Inc.

Via GlobeNewswire

BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

September 06, 2023

From BioAtla, Inc.

Via GlobeNewswire

BioAtla to Participate in Upcoming Investor Conferences in August

August 03, 2023

From BioAtla, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

BioAtla, Inc. - Common Stock (NQ:BCAB)

All News about BioAtla, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today